NATCO Pharma Ltd.
Share Price Target & Analysis
NSE:NATCOPHARM
VWAP
Open
Close
High
Low
52 Week High
-5.85 (-0.71%)
NATCOPHARM
(PHARMA)Watch Carefully
52 Week Low
EPS
PE
PB
Deluxe
Quality
Steel
Valuation
#Analysis
NSE: NATCOPHARM Share Price Financial Analysis & Valuation
NATCO Pharma Ltd. (NATCOPHARM) is broadly categorized in PHARMA segment industry which deals in Pharmaceuticals vertical.
It is one of Small Cap company with Market Capitalization of Rs 16084.6 (in Cr). Total number of free float shares are 18.2 (in Lacs).
NATCO Pharma Ltd. is listed on NSE with Exchange ID - INE987B01026 and trading code is NSE:NATCOPHARM with short name Natco Pharma.
In the past 1 year, NATCO Pharma Ltd. has declared an equity dividend of Rs 0.61 per share. At the current share price of NATCOPHARM at Rs 813.30, this results in a dividend yield of 0.08 %.
As per the Fundamental Analysis of NSE:NATCOPHARM, which uses revenues, earnings, future growth, financial ratios, return on equity, profit margins, and other data to determine NATCOPHARM underlying value and future prospects. All of this data is available in NATCOPHARM financial statements.
Quality of the Stock: As per the fundamental analysis of NSE:NATCOPHARM, it is clearly understood that NATCOPHARM is Deluxe performer in terms of earnings and profit margins with an EPS of 82.14. NSE:NATCOPHARM book value per share as of today is 481.67. The current price to book ratio for NATCOPHARM as of Sep 16, 2026 is 1.69.
Valuation of the Stock: The current valuation of NATCOPHARM stock is like Steel which means currently the stock is Moderately Priced. Now, it's totally depends upon the risk appetite of an investor and risk-reward ratio of NATCOPHARM whether to BUY this stock at current valuation. The delivery percentage of NATCOPHARM is 210940% is very crucial parameter which shows that 210940% investors are anticipating that the price of NATCOPHARM share should go up with VWAP at 814.88.
Now, the main question is whether to BUY or SELL, NSE:NATCOPHARM at current valuation.
As per latest Analysis No. #4197:-
⇑ STRONG BUY NATCOPHARM if All Greens
⇗ BUY NATCOPHARM (at Lower Levels) if any 2 Greens
⇒ NEUTRAL or HOLD NATCOPHARM (With Stop Loss) if only 1 Green
⇘ SELL NATCOPHARM if NO Green Indicator
NSE: NATCOPHARM Share Price Today (Sep 16, 2026)
(NATCO Pharma Ltd. Daily Analysis on the basis of NATCOPHARM Intraday Graph & Trend)
NATCO Pharma Ltd. share price moved Down by -0.71% from its previous close of Rs 819.15. NATCOPHARM stock last traded price is 813.30. NATCOPHARM share price trend is Down with a total of 492595 stocks traded till now. It has touched an intraday high of Rs 828.75 and an intraday low of Rs 801. The NATCOPHARM trading at 813.30, Down by Rs. -5.85, or -0.71 percent which suggests that most of the Traders are anticipating that the price of NATCOPHARM share should go Down.
NSE: NATCOPHARM Share Price Tomorrow Prediction
(NATCO Pharma Ltd. Share Price Prediction for Tomorrow & future forecast is based on Current Trend of NATCOPHARM)
NATCO Pharma Ltd. share price moved Down by -0.71%. NATCOPHARM share price short term trend is Down. It suggests that NATCOPHARM Share Price for Tomorrow remains the same with VWAP at 814.88 will be treated as stop loss for intraday traders. NATCO Pharma Ltd. Long term investors can follow the NATCOPHARM long term trend as mentiond in future forecast table.
NSE Code |
NSE: NATCOPHARM |
NATCOPHARM Share Price Today |
813.30 |
NATCOPHARM Share Price Target Prediction for 2026 ^ |
827.2 - 1069.7 |
NATCOPHARM Share Price Target Prediction for 2027*^ |
1069.7 - 1313.4 |
NATCOPHARM Share Price Target Prediction for 2028*^ |
1313.4 - 1405.3 |
NATCOPHARM Share Price Target Prediction for 2029*^ |
1476 |
NATCOPHARM Share Price Target Prediction for 2030*^ |
1518 |
NATCOPHARM Share Price Target Prediction for 2035*^ |
1654 |
| NATCOPHARM Current Book Value |
479.3 |
*NATCO Pharma Ltd. Short Term & Long Term share price target is based on current financial year earings of the company.
^NATCOPHARM share price target prediction for 2026 2027 2028 2029 2030 to 2035 is based on current market scenario, future forecast & growth assumptions, they might change subject to market sentiments.
NATCOPHARM Technical Analysis
Candlestick Pattern: @826.3| MA | Simple | Action S1 | Expo | Action E2 |
|---|---|---|---|---|
| MA_5 | 831.46 | SELL | 832.16 | SELL |
| MA_12 | 847.41 | SELL | 847.78 | SELL |
| MA_20 | 865.3 | SELL | 860.37 | SELL |
| MA_32 | 887.89 | SELL | 880.16 | SELL |
| MA_50 | 909.61 | SELL | 897.75 | SELL |
| MA_100 | 953.65 | SELL | 923.39 | SELL |
| MA_200 | 945.67 | SELL | 946.29 | SELL |
| Trend Oscillators | Value | Action |
|---|---|---|
| Bollinger Bands | 865.3 | Downtrend |
| MACD | -2.01 | SELL |
| ADX | 17.29 | NO or Weak Trend |
| DMI (+/-) | 11.47 / 21.5 | Downtrend |
| Momentum Oscillators | Value | Action |
|---|---|---|
| RSI | 31.4 | Neutral |
| STOCHASTIC_K (Fast) | 26.78 | Neutral |
| STOCHASTIC_D (Slow) | 23.53 | Neutral |
| CCI | -106.81 | SELL |
| PSAR | 853.42 | SELL |
| TRUE RANGE | 23.7 | Neutral |
| ATR | 22.22 | Neutral |
| WILLIAMS R | -86.91 | Oversold |
| TRIX | 0 | Neutral |
| STOCHASTIC RSI K | 44.31 | Neutral |
| STOCHASTIC RSI D | 60.93 | Neutral |
| MOMENTUM | -80.7 | SELL |
| Duration | Value |
|---|---|
| 1 Year | -3.42% |
| 3 Months | -4.47% |
| 1 Month | -8.9% |
| 1 Week | -2.01% |
| Action | Overall (%) |
|---|---|
| BUY | 0% |
| NEUTRAL / HOLD | 30% |
| SELL | 70% |
Most popular Questions & Answers about NATCOPHARM (/ FAQ NATCOPHARM)
NATCO Pharma Ltd. stock last traded price is 813.30. NATCOPHARM share price moved Down by -0.71% from its previous close of Rs 819.15.
NATCO Pharma Ltd. share price trend is Down with a total of 492595 stocks traded till now. It has touched an intraday high of Rs 1239.068 and an intraday low of Rs 801. The NATCOPHARM trading at 813.30, Down by Rs. -5.85, or -0.71 percent which suggests that most of the Traders are anticipating that the price of NATCOPHARM share should go Down and the Stop Loss will be around 814.88.
The market cap of NATCO Pharma Ltd. is ₹16084.6 (in Cr) as of Sep 15, 2026.
The current price to earning ratio for NATCO Pharma Ltd. as of Sep 15, 2026 is 16.33.
The current price to book ratio for NATCO Pharma Ltd. as of Sep 15, 2026 is 1.69.
The highest price of NATCO Pharma Ltd. stock is ₹1226.8 in the last 52-week.
The lowest price of NATCO Pharma Ltd. stock is ₹789 in the last 52-week.
NATCO Pharma Ltd. share trading at ₹813.30, Down by Rs. -5.85, or -0.71 percent which suggests that most of the traders are anticipating that the price of NATCOPHARM share should go Down.
In 2026, Stock price target for NATCO Pharma Ltd. (NATCOPHARM) will be around ₹827.2 on downside and ₹1069.7 on upside. NATCO Pharma Ltd. share price target is based on current financial year earings of the company.
In 2027, Stock price target for NATCO Pharma Ltd. (NATCOPHARM) will be around ₹1069.7 on downside and ₹1313.4 on upside. NATCO Pharma Ltd. share price target is based on forecasted future earnings of the company.
In 2028, Stock price target for NATCO Pharma Ltd. (NATCOPHARM) will be around ₹1313.4 on downside and ₹1405.3 on upside. NATCO Pharma Ltd. share price target is based on Discounted Cash Flow (DCF) method uses the projected future cash flows of the business.
In next five years, Stock price target for NATCO Pharma Ltd. (NATCOPHARM) will be around ₹1518 NATCO Pharma Ltd. share price target is based on market scenario & growth assumptions, they might change subject to market sentiments and forecasted future earnings of NATCOPHARM.
The price of NATCO Pharma Ltd. (NATCOPHARM) shares moved by -0.71%. The short-term trend for NATCOPHARM share price is Down. It implies that the share price of NATCOPHARM will stay the same tomorrow and that intraday traders should treat VWAP at 814.88 as a stop loss. Investors with a long-term outlook can track NATCOPHARM long-term trajectory, which is indicated in the future forecast table.
Estimated DCF Value of NATCOPHARM stock is 984.9. Compared to the current market price of 813.30 INR, the NATCOPHARM stock is Undervalued by 17.4%.
As per the fundamental analysis of NATCO Pharma Ltd. (NATCOPHARM), it is of Deluxe quality in terms of earnings and profit margins with an EPS of 82.14. NATCO Pharma Ltd. book value per share as of today is 481.67. The current price to book ratio for NATCOPHARM as of Sep 16, 2026 is 1.69.
NSE:NATCOPHARM News & Other Useful Information about NATCOPHARM Share Price
Peer Comparison of NSE: NATCOPHARM
The Peers list includes companies operating in the same industry and having comparable market cap.
Sector: Pharmaceuticals
| Company | Price | EPS | BV |
|---|---|---|---|
| SUNPHARMA | 1853.50 | 16.35 | 97.89 |
| DIVISLAB | 9158.00 | 115.55 | 663.06 |
| MEDICAMEQ | 345.50 | 12.15 | 208.08 |
| CIPLA | 1358.00 | 51.67 | 434.03 |
| DRREDDY | 1140.00 | 53.19 | 380.63 |
| TORNTPHARM | 4812.50 | 87.32 | 235.7 |
| BIOCON | 374.40 | 1.27 | 166.51 |
| LUPIN | 2045.00 | 154.86 | 718.37 |
| ALKEM | 5175.00 | 212.33 | 1218.48 |
| AUROPHARMA | 1643.00 | 46.49 | 403.84 |
| ABBOTINDIA | 26125.00 | 766.11 | 2448.41 |
| GLAXO | 2856.20 | 63.65 | 147.25 |
| IPCALAB | 1950.70 | 56.72 | 329.23 |
| LAURUSLABS | 1905.50 | 20.74 | 102.57 |
| LALPATHLAB | 1895.70 | 39.68 | 157.23 |
| PFIZER | 4014.40 | 170.54 | 963.41 |
| AJANTPHARM | 3508.90 | 89.3 | 363.23 |
| SANOFI | 3111.20 | 158.05 | 332.96 |
| NATCOPHARM | 813.30 | 82.14 | 481.67 |
| APLLTD | 825.30 | 48.4 | 295.69 |
| JBCHEPHARM | 2408.90 | 54.16 | 251.48 |
| GLENMARK | 2410.00 | 1.24 | 881.78 |
| AAREYDRUGS | 99.94 | 2.39 | 53.38 |
| JUBLPHARMA | 1002.50 | 4.35 | 145.63 |
| SPARC | 185.59 | 48.14 | 40.45 |
| GRANULES | 835.60 | 23.25 | 180.42 |
| ASTRAZEN | 6703.00 | 86.44 | 364.29 |
| CAPLIPOINT | 2583.00 | 55.52 | 285.6 |
| FDC | 350.20 | 21.19 | 161.21 |
| HIKAL | 224.38 | 9.34 | 96.63 |